至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

Nat. Cell Biol.. 2019-03; 
NakamuraKyosuke,SarediGiulia,BeckerJordan R,FosterBenjamin M,NguyenNhuong V,BeyerTracey E,CesaLaura C,FaullPeter A,LukauskasSaulius,FrimurerThomas,ChapmanJ Ross,BartkeTill,Groth
Products/Services Used Details Operation
Gene Synthesis A fragment of BARD1 encompassing the ARD (amino acids 406-558) was synthetized by GenScript to contain silent mutations to generate siRNA resistance (5′ – AAGCTGcTGCCtAAcATGGCc – 3′) in combination with BARD1 ARD mutations (N470A, N470S, E467A, D500A and N470AE467AD500A (ARD 3A)). Get A Quote

摘要

Genotoxic DNA double-strand breaks (DSBs) can be repaired by error-free homologous recombination (HR) or mutagenic non-homologous end-joining. HR supresses tumorigenesis, but is restricted to the S and G2 phases of the cell cycle when a sister chromatid is present. Breast cancer type 1 susceptibility protein (BRCA1) promotes HR by antagonizing the anti-resection factor TP53-binding protein 1(53BP1) (refs. ), but it remains unknown how BRCA1 function is limited to the S and G2 phases. We show that BRCA1 recruitment requires recognition of histone H4 unmethylated at lysine 20 (H4K20me0), linking DSB repair pathway choice directly to sister chromatid availability. We identify the ankyrin repeat domain of BRC... More

关键词